Neuregen Therapeutics Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Neuregen Therapeutics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma (NCT07710690) | Neuregen Therapeutics Co., Ltd. | 2026-07-09 |
Track Neuregen Therapeutics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.